P. Salk

发表

Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line.

S. Karpatkin, G. Yogeeswaran, E. Pearlstein, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination.

R. Moss, F. Jensen, D. Carlo, 1998, Vaccine.

ROLE OF PLATELETS IN TUMOR CELL METASTASES

S. Karpatkin, G. Yogeeswaran, E. Pearlstein, 1981, Annals of internal medicine.

Cell-mediated immunologic memory in prevention and treatment of HIV disease.

J. Salk, P. Salk, 1994, Research in immunology.

Induction of humoral and cellular immunity to simian immunodeficiency virus: what are the requirements for protection?

P. Roques, D. Dormont, O. Benveniste, 1994, Vaccine.

A strategy for prophylactic vaccination against HIV.

M. Clerici, G. Shearer, J. Salk, 1993, Science.

Role of platelets in tumor cell metastases.

S. Karpatkin, G. Yogeeswaran, E. Pearlstein, 1981, Annals of the New York Academy of Sciences.

Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines.

G. Yogeeswaran, P. Salk, 1981, Science.

Cell Surface Sialylation of Metastatic Variant Murine Tumor Cell Lines

G. Yogeeswaran, P. Salk, 1980 .

Can AIDS be prevented by T-cell vaccination?

H Atlan, M. Gersten, H. Atlan, 1993, Immunology today.

Isolation and partial characterization of human T-cell growth factor.

G. Dennert, P. Böhlen, F. Esch, 1983, Biochemical and biophysical research communications.

Vaccination with gp120-depleted HIV-1 plus immunostimulatory CpG oligodeoxynucleotides in incomplete Freund's adjuvant stimulates cellular and humoral immunity in rhesus macaques.

R. Moss, K. Manson, P. Silvera, 2004, Vaccine.

Detection and elimination of cellular nucleic acids in biologicals produced on continuous cell lines.

C. V. van Beveren, J. Salk, A. V. van Wezel, 1981, Developments in biological standardization.

Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up.

F. Jensen, D. Carlo, S. Groshen, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1: Report* from a meeting of the WHO-UNAIDS Vaccine Advisory Committee** Geneva, 21–23 February 2000

Guido Ferrari, N. Nathanson, Donald S. Burke, 2001, AIDS.

Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention

M. Gersten, H. Atlan, J. Salk, 1994, Research in Immunology.